The above data demonstrated that GLUT8 is required for maximal fructose delivery across the hepatocyte plasma membrane and that genetic GLUT8 ablation blocked fructose-induced steatosis in vivo without changes in hepatic fat oxidation markers or insulin signaling. The gene discussed is SLC2A8; the disease is steatosis.